WHO Pharmaceuticals Newsletter 2002, No. 03
(2002; 22 pages) Voir le document au format PDF
Table des matières
Ouvrir ce répertoire et afficher son contenuREGULATORY MATTERS
Fermer ce répertoireSAFETY OF MEDICINES
Afficher le documentBUPROPION - Safety update
Afficher le documentDICLOFENAC & OTHERS - ADR update from Singapore
Afficher le documentGENTAMICIN EAR DROPS - Risk of ear toxicity in patients with non-intact eardrums
Afficher le documentGRAPEFRUIT JUICE - Potential for drug interactions
Afficher le documentMIFEPRISTONE - New safety information
Afficher le documentMIGLUSTAT - Temporary withdrawal
Afficher le documentPALIZUMAB, QUINUPRISTIN + DALFOPRISTIN - Similar proprietary names could result in medication errors
Afficher le documentPERGOLIDE - Fibrotic reactions with ergot-derived dopamine receptor agonists
Afficher le documentPROCARBAZINE - Risk of lung cancer in Hodgkin’s patients
Afficher le documentSILDENAFIL - 3 years’ post-marketing experience
Afficher le documentTICARCILLIN - Haemorrhagic cystitis in patients with cystic fibrosis
Afficher le documentTOPIRAMATE - Reports of acute myopia
Ouvrir ce répertoire et afficher son contenuDRUGS OF CURRENT INTEREST
Ouvrir ce répertoire et afficher son contenuFEATURE
Afficher le documentEVENTS & ANNOUNCEMENTS
 

GRAPEFRUIT JUICE - Potential for drug interactions

Canada. Health Canada is advising the public not to take grapefruit or its juice (fresh or frozen) with certain drugs since several substances in grapefruit may interfere with their metabolism, leading to higher blood levels of these drugs with serious and even life-threatening adverse reactions. Affected products include (but not limited to) drugs used in treating medical conditions such as angina, anxiety, cancer, convulsions, depression, erectile dysfunction, gastrointestinal reflux, high blood pressure, high lipid cholesterol levels, HIV/AIDS, infections, irregular heart rhythms, organ graft rejections and psychotic problems. As little as one glass of grapefruit juice can cause an increased blood drug level and the effects can last for three days or more. Health Canada has issued several communication documents to remind health professionals of possible interactions between grapefruit and drugs. In addition, Health Canada is working with drug manufacturers whose products are adversely affected by grapefruit, to ensure that the relevant information is placed on the product label.

Reference:

Health Canada Warnings/ Advisories, 21 Jun 2002.
Available from URL: http://www.hc-sc.gc.ca

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013